Internet-based cognitive testing in multiple sclerosis.

Area of Science:

• Neuroscience
• Clinical Neurology

Background:

• Cognitive impairment is a significant challenge in multiple sclerosis (MS) due to disease heterogeneity.
• Traditional neurocognitive testing is time-consuming and costly, limiting its widespread use.
• The Paced Auditory Serial Addition Test (PASAT) is a proposed screening tool for MS-related cognitive changes.

Observation:

• This study investigated the efficacy of the Cognitive Stability Index (CSI) for assessing cognitive function in MS patients via the internet.
• The CSI was compared against formal neurocognitive testing (NPsych) and the PASAT in 40 MS patients with cognitive complaints.
• NPsych identified cognitive impairment in 46% of the participants.

Findings:

• The CSI demonstrated high sensitivity (83%) in detecting cognitive impairment, significantly outperforming the PASAT (28%).
• Both CSI and PASAT showed comparable specificity (86%).
• The CSI proved to be a more sensitive measure for cognitive impairment in MS compared to the PASAT.

Implications:

• The internet-based CSI offers a scalable and accessible tool for screening and monitoring cognitive function in multiple sclerosis.
• Its high sensitivity suggests the CSI can aid in early identification of cognitive deficits in MS patients.
• The CSI has the potential to streamline clinical trials and routine patient follow-up for cognitive changes in MS.